199 results
424B3
RGBP
Regen BioPharma Inc
24 Apr 24
Prospectus supplement
1:28pm
for the marketing and sale of any of the Company’s products and therapies and no assurance may be given that any of the Company’s products or therapies … or, alternatively, advance the application further to Phase III clinical trials. The Company can provide no assurance that the Company will be able
424B3
RGBP
Regen BioPharma Inc
19 Jan 24
Prospectus supplement
1:29pm
of the Company’s products and therapies and no assurance may be given that any of the Company’s products or therapies will be granted such approval … the application further to Phase III clinical trials. The Company can provide no assurance that the Company will be able to sell or license any product
424B3
p3c7pi
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.2
b59vldnsn ok3yhpa1r
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.1
s1ki tn5vordfa2j
20 Nov 23
Prospectus supplement
9:38am
424B3
b1mwj8i41
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.1
n3nt2wrq5
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm